EUVIMEDEUVIMED entdecken
Crossref

Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes

Riccardo M Inciardi, Robert P Giugliano, Jeong-Gun Park, Francesco Nordio, Christian T Ruff, Cathy Chen, Hans-Joachim Lanz, Elliott M Antman, Eugene Braunwald, Scott D Solomon

JACC: Clinical Electrophysiology · 2023

DOI: 10.1016/j.jacep.2022.11.032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2023. Verfasst von Riccardo M Inciardi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardio…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Stroke. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Daiichi Sankyo Co Ltd.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The risks of heart failure (HF) events compared with stroke/systemic embolic events (SEE) or major bleeding (MB) in heart failure with reduced ejection fraction (HFrEF) vs heart failure with preserved ejection fraction (HFpEF) in a large atrial fibrillation (AF) population have not been well-studied. OBJECTIVES: This study sought to assess HF outcomes, according to HF history and HF phenotypes (HFrEF vs HFpEF), and compare these events with SEE and MB, among patients with AF. METHODS: We analyzed patients enrolled in the ENGAGE-AF TIMI 48 (Effective Anticoagulation with Factor Xa Next Generation in AF-Thrombolysis in Myocardial Infarction 48) trial. Cumulative incidence of heart failure hospitalization (HHF) or HF death was assessed and compared with the rates of fatal and nonfatal stroke/SEE and MB over a median follow-up of 2.8 years. RESULTS: Overall, 12,124 (57.4%) had a history of HF (37.7% HFrEF, 40.1% HFpEF, 22.1% with unknown ejection fraction). The rate per 100 person-years (py) of HHF or HF death (4.95; 95% CI: 4.70-5.20) was higher than of fatal and nonfatal stroke/SEE (1.77; 95% CI: 1.63-1.92) and MB (2.66; 95% CI: 2.47-2.86) among patients with HF history. HFrEF patients experienced a higher rate of HHF or HF death compared with HFpEF patients (7.15 vs 3.65; P < 0.001), while the rates of fatal and nonfatal stroke/SEE and MB were similar by HF phenotype. Patients with HF history had a higher rate of mortality after a HHF (1.29; 95% CI: 1.17-1.42) than after a stroke/SEE (0.69; 95% CI: 0.60-0.78) or after MB (0.61; 95% CI: 0.53-0.70). Overall, patients with nonparoxysmal AF had a higher rate of HF and stroke/SEE events regardless of HF history. CONCLUSIONS: Patients with AF and HF, regardless of ejection fraction, are at a higher risk of HF events with higher subsequent mortality rates than of stroke/SEE or MB. While HFrEF is associated with a higher risk of HF events than HFpEF, the risk of stroke/SEE and MB is similar between HFrEF and HFpEF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureStrokeHumansPrognosisStroke VolumeHemorrhage

Stichwörter der Autor:innen

atrial fibrillationheart failuremajor bleedingstroke/systemic embolic events

Autor:innen und Institutionen

  • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiology, Department of Medical and Surgical Specialties, Radiological Sci…
  • TIMI Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Cardiovascular, Metabolic and Renal Disease Therapeutic Area, Global Clinical Development, Daiichi Sankyo Pharma Development, Basking Ridge, New Jersey, USA.
  • Daiichi Sankyo Europe GmbH, Munich, Germany.
  • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: ssolomon@bwh.harvard.edu.

Förderung

  • Daiichi Sankyo Co Ltd

Zitieren

APA

Inciardi, R. M., Giugliano, R. P., Park, J. G., Nordio, F., Ruff, C. T., Chen, C., Lanz, H. J., Antman, E. M., Braunwald, E., & Solomon, S. D. (2023). Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2022.11.032

Vancouver

Inciardi RM, Giugliano RP, Park JG, Nordio F, Ruff CT, Chen C, et al. Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes. JACC: Clinical Electrophysiology. 2023. doi:10.1016/j.jacep.2022.11.032

BibTeX
@article{Inciardi2023,
  author = {Inciardi, Riccardo M and Giugliano, Robert P and Park, Jeong-Gun and Nordio, Francesco and Ruff, Christian T and Chen, Cathy and Lanz, Hans-Joachim and Antman, Elliott M and Braunwald, Eugene and Solomon, Scott D},
  title = {Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes},
  journal = {JACC: Clinical Electrophysiology},
  year = {2023},
  doi = {10.1016/j.jacep.2022.11.032}
}
Kostenlos starten →